Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Physiological Sciences : JPS|September 9, 2011
Intermittent arm ischemia induces vasodilatation of the contralateral upper limbKenki Enko, Kazufumi Nakamura, Kei Yunoki, et al.
Atherosclerosis|November 26, 2013
Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery diseaseKei Yunoki, Takahiko Naruko, Mayumi Inaba, et al.
Nutrients|August 11, 2017
Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic AcidYukihiro Saito, Kazufumi Nakamura, Daiji Miura, et al.
European Heart Journal|June 27, 2009
Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromesKei Yunoki, Takahiko Naruko, Ryushi Komatsu, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|May 1, 2013
Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal diseaseChizuko Kitabayashi, Takahiko Naruko, Kenichi Sugioka, et al.
Pharmaceuticals (Basel, Switzerland)|January 22, 2016
Beta-Blockers and Oxidative Stress in Patients with Heart FailureKazufumi Nakamura, Masato Murakami, Daiji Miura, et al.
Plos One|March 27, 2020
One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantationMasahiro Natsuaki, Takeshi Morimoto, Erika Yamamoto, et al.
Cardiovascular Intervention and Therapeutics|November 1, 2015
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trialMasahiro Natsuaki, Takeshi Morimoto, Erika Yamamoto, et al.
Pageof 4